{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Immunovia Announces Investor Relations Changes - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"RFbBYf2XAa\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovia-announces-investor-relations-changes\/\">Immunovia Announces Investor Relations Changes<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovia-announces-investor-relations-changes\/embed\/#?secret=RFbBYf2XAa\" width=\"600\" height=\"338\" title=\"&#8220;Immunovia Announces Investor Relations Changes&#8221; &#8212; Market Newsdesk\" data-secret=\"RFbBYf2XAa\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"PR Newswire LUND Sweden, Dec. 7, 2020 \/PRNewswire\/ &#8212;\u00a0Immunovia AB (publ) (&#8220;Immunovia&#8221;) a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray\u2122 for the early detection of cancer, announced today that Julie Silber, Senior Director of Investor Relations has stepped down from her position to pursue other opportunities effective November 30, 2020. CEO, Patrik Dahlen will assume the Investor Relations duties immediately. &#8220;We appreciate the many contributions Julie made since joining the Immunovia team as Director of IR. We would like to thank Julie for her time at Immunovia,&#8221; stated Patrik Dahlen, CEO of Immunovia. For more information, please contact: Patrik Dahlen, CEO ImmunoviaEmail: patrik.dahlen@immunovia.comTel: +46 73 376 76 64 About\u00a0Immunovia Immunovia AB is a diagnostic &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO15383&amp;sd=2020-12-07"}